Increased radiation-induced apoptosis of Saos2 cells via inhibition of NFκB: A role for c-Jun N-terminal kinase

Center for Musculoskeletal Research, University of Rochester Medical Center, Rochester, New York 14642, USA.
Journal of Cellular Biochemistry (Impact Factor: 3.37). 12/2005; 96(6):1262-73. DOI: 10.1002/jcb.20607
Source: PubMed

ABSTRACT To elucidate the possible effect of NFkappaB on radioresistance, we used the osteosarcoma cell line Saos2, stably expressing the NFkappaB constitutive inhibitor, mIkappaB (Saos2-mIkappaB) or stably transfected with the empty vector (Saos2-EV). Ionizing radiation induced "intrinsic" apoptosis in Saos2-mIkappaB cells but not in Saos2-EV control cells, with intact NFkappaB activity. We find as expected, that this NFkappaB activity was enhanced following irradiation in the Saos2-EV control cells. On the other hand, inhibition of NFkappaB signaling in Saos2-mIkappaB cells led to the upregulation of the pro-apoptotic systems, such as Bax protein and c-Jun N-terminal Kinase (JNK)/c-Jun/AP1 signaling. Inhibition of NFkappaB resulted in decreased expression of the DNA damage protein GADD45beta, a known inhibitor of JNK. Subsequently, JNK activation of c-Jun/AP-1 proteins increased radiation-induced apoptosis in these mutants. Radiation-induced apoptosis in Saos2-mIkappaB cells was inhibited by the JNK specific inhibitor SP600125 as well as by Bcl-2 over-expression. Furthermore, release of cytochrome-c from mitochondria was increased and caspase-9 and -3 were activated following irradiation in Saos2-mIkappaB cells. Antisense inhibition of GADD45beta in Saos2-EV cells significantly enhanced apoptosis following irradiation. Our results demonstrate that radioresistance of Saos2 osteosarcoma cells is due to NFkappaB-mediated inhibition of JNK. Our study brings new insight into the mechanisms underlying radiation-induced apoptosis of osteosarcoma, and may lead to development of new therapeutic strategies against osteosarcoma.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Osteosarcoma (OS) is an aggressive bone malignancy with poor prognosis. Many OS cells are resistant to apoptotic induction by tumor necrosis factor-related apoptosis inducing ligand (TRAIL). In our previous study, we found that the serum level of cytochrome c1 (CYC1) is significantly higher in OS patients than in healthy subjects. Our aim was to investigate the effects of CYC1 silencing on TRAIL-induced apoptosis in human OS in vitro and in vivo along with the underlying mechanisms. First, we determined the expression of CYC1 in human OS tumors and cell lines versus normal adjacent tissues and cell line. We then studied the effects of CYC1 silencing alone or in combination with TRAIL on OS cell growth and apoptosis in vitro and OS tumorigenesis in vivo. We found that CYC1 is overexpressed in human OS tissues and cell lines. CYC1 silencing by shRNA transfection inhibits proliferation, slightly induces apoptosis in human OS cells in vitro, and suppresses human OS tumor growth in a mouse xenograft model in vivo. Additionally, CYC1 silencing sensitizes OS to TRAIL-induced apoptosis in vitro and in vivo. Our results also showed that CYC1 silencing significantly reduces complex III activity and potentiates TRAIL-induced cytochrome c release and caspase-9 activation in OS cells, suggesting that CYC1 silencing acts via the mitochondria-dependent apoptotic pathway. Taken together, our results provide evidence that CYC1 plays an important role in OS tumorigenesis, and modulation of CYC1 may be an effective strategy to potentiate OS to apoptotic induction by TRAIL. © 2015 S. Karger AG, Basel.
    Cellular Physiology and Biochemistry 01/2014; 34(6):2070-80. DOI:10.1159/000366402 · 3.55 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Metabolic re-programming in cancer is manifested by persistent aerobic glycolysis and suppression of mitochondrial function and is known as the Warburg effect. The Warburg effect contributes to cancer progression and is considered to be a promising therapeutic target. Understanding mechanisms used by cancer cells to suppress their mitochondria may lead to development of new approaches to reverse the metabolic re-programming. We have evaluated mitochondrial function and morphology in poorly respiring LM7 and 143B osteosarcoma cell lines showing the Warburg effect in comparison to actively respiring Saos2 and HOS osteosarcoma cells and non-cancerous osteoblastic hFOB cells. In LM7 and 143B cells we detected markers of the mitochondrial permeability transition (MPT), such as mitochondrial swelling, depolarization and membrane permeabilization. In addition, we detected mitochondrial swelling in human osteosarcoma xenografts in mice and archival human osteosarcoma specimens using electron microscopy. The MPT inhibitor, sanglifehrin A, reversed MPT markers and increased respiration in LM7 and 143B cells. Our data suggest that the MPT may play a role in suppression of mitochondrial function contributing to the Warburg effect in cancer.
    Journal of Biological Chemistry 10/2013; DOI:10.1074/jbc.M113.507129 · 4.60 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Very few studies have been reported the function of wild type IDH1 in tumor progress. Previously, we reported that IDH1 correlated with pathological grade and metastatic potential inversely in human osteosarcoma. Here, IDH1 was found lower expressed in osteosarcoma tissues than that of adjacent normal bone tissues. In addition, we observed in vitro anti-proliferation and pro-apoptosis effects of up-regulated IDH1 on osteosarcoma cell lines. The migration and invasion activity was also markedly reduced by IDH1 up-regulation. Unexpectedly, IDH1 up-regulation also suppressed tumor growth and metastasis in vivo. Therefore, IDH1 may represent a potential novel treatment and preventive strategy for osteosarcoma.
    Cancer letters 12/2013; 346(1). DOI:10.1016/j.canlet.2013.12.020 · 5.02 Impact Factor